title: [Isolation rate of Pseudomonas aeruginosa from surgical infections and their susceptibilities].
abstract: Pseudomonas aeruginosa isolated from surgical infections during the period from July 1982 to June 1995 were investigated in a multicenter study involving 19 hospitals in Japan, and the following results were obtained. 1. Though the isolation rate of P. aeruginosa was not high from primary infections, it was more frequently isolated from postoperative infections throughout the study period. Enterococcus spp., P. aeruginosa and Staphylococcus aureus including MRSA were predominant among postoperative infections. From the postoperative cases that had previous antibiotic treatment, Enterococcus spp., MRSA and P. aeruginosa were more predominantly isolated than from those without previous treatments with antibiotics. 2. Cefozopran, ceftazidime, cefsulodin, aztreonam, carumonam, gentamicin, amikacin and ofloxacin had strong activities against P. aeruginosa. We recognize recently that antibiotic-resistant strains of P. aeruginosa against imipenem and ofloxacin have been increasing year by year.
authors.affiliation: Department of Surgery, Nagoya City Koseiin Hospital.
authors.forename: N
authors.initials: N
authors.lastname: Shinagawa
authors.forename: J
authors.initials: J
authors.lastname: Yura
authors.forename: T
authors.initials: T
authors.lastname: Manabe
authors.forename: K
authors.initials: K
authors.lastname: Mashita
authors.forename: S
authors.initials: S
authors.lastname: Ishikawa
authors.forename: A
authors.initials: A
authors.lastname: Mizuno
authors.forename: K
authors.initials: K
authors.lastname: Hirata
authors.forename: R
authors.initials: R
authors.lastname: Denno
authors.forename: M
authors.initials: M
authors.lastname: Mukaiya
authors.forename: K
authors.initials: K
authors.lastname: Ishibiki
authors.forename: Y
authors.initials: Y
authors.lastname: Ushijima
authors.forename: N
authors.initials: N
authors.lastname: Aikawa
authors.forename: K
authors.initials: K
authors.lastname: Takuma
authors.forename: S
authors.initials: S
authors.lastname: Iwai
authors.forename: M
authors.initials: M
authors.lastname: Kunimatsu
authors.forename: K
authors.initials: K
authors.lastname: Ohtsuka
authors.forename: H
authors.initials: H
authors.lastname: Kinoshita
authors.forename: K
authors.initials: K
authors.lastname: Morimoto
authors.forename: M
authors.initials: M
authors.lastname: Fujimoto
authors.forename: H
authors.initials: H
authors.lastname: Tanimura
authors.forename: H
authors.initials: H
authors.lastname: Ohnishi
authors.forename: Y
authors.initials: Y
authors.lastname: Umemoto
authors.forename: S
authors.initials: S
authors.lastname: Sakaguchi
authors.forename: H
authors.initials: H
authors.lastname: Dounishi
authors.forename: S
authors.initials: S
authors.lastname: Oda
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002761:Cholangitis / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects / Q000302:isolation & purification; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D016106:Methicillin Resistance; D010538:Peritonitis / Q000382:microbiology*; D011183:Postoperative Complications; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents